deltorphin i, ala(2)- has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies
Studies (deltorphin i, ala(2)-) | Trials (deltorphin i, ala(2)-) | Recent Studies (post-2010) (deltorphin i, ala(2)-) | Studies (1,3-dipropyl-8-cyclopentylxanthine) | Trials (1,3-dipropyl-8-cyclopentylxanthine) | Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine) |
---|---|---|---|---|---|
122 | 0 | 4 | 1,301 | 1 | 165 |
Protein | Taxonomy | deltorphin i, ala(2)- (IC50) | 1,3-dipropyl-8-cyclopentylxanthine (IC50) |
---|---|---|---|
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0051 | |
Adenosine receptor A3 | Rattus norvegicus (Norway rat) | 0.0038 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.2033 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.0234 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagley, EE; Chieng, BC; Christie, MJ; Hack, SP | 1 |
1 other study(ies) available for deltorphin i, ala(2)- and 1,3-dipropyl-8-cyclopentylxanthine
Article | Year |
---|---|
Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Excitatory Amino Acid Antagonists; G Protein-Coupled Inwardly-Rectifying Potassium Channels; gamma-Aminobutyric Acid; Glycine Agents; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Narcotic Antagonists; Narcotics; Neurons; Oligopeptides; Patch-Clamp Techniques; Periaqueductal Gray; Protein Kinase Inhibitors; Receptors, Opioid, delta; Receptors, Opioid, mu; Strychnine; Sulfonamides; Synaptic Transmission; Time Factors; Xanthines | 2005 |